Department of Physics, The George Washington University, Washington, DC 20052, USA.
Med Phys. 2010 Jun;37(6):2435-40. doi: 10.1118/1.3425789.
The authors have developed a novel technique using an electronic portal imaging device (EPID) to verify the geometrical accuracy of delivery of dose-rate-regulated tracking (DRRT). This technique, called verification of real-time tracking with EPID (VORTE), can potentially be used for both on-line and off-line quality assurance (QA) of MLC-based dynamic tumor tracking.
The shape and position of target as a function of time, which is assumed to be known, is projected onto the EPID plane. This projected sequence of apertures as a function of time (target motion) is then used as the reference. The accuracy of dynamic MLC tracking can then be assessed by how well the delivered beam follows this projected target motion without the use of a physical moving phantom. The beam apertures controlled by DRRT (aperture motion) is detected by the EPID as a function of time. The aperture motion is compared to the target motion to evaluate tracking error introduced by DRRT. The accuracy of VORTE was measured using film measurements of ten static fields. The VORTE for dynamic tumor tracking was tested with several target motions, including (1) rigid-body two-dimensional (2-D) cyclic motion in the superior-inferior direction with various period and amplitude; (2) the above 2-D cyclic motion plus cyclic deformation; and (3) 2-D cyclic motion with both deformation and rotation. For each target motion, the controlled aperture motion resulting from DRRT was acquired at approximately 8 Hz using EPID in the continuous-acquisition mode. Leaf positions in all captured frames were measured from the EPID and compared to their expected positions. The passing rate of 2 mm criteria for all leaves from all frames was calculated for each of the four patterns of tumor motion. Additionally, the root-mean-square (RMS) deviations of the centroid of the apertures between the designed and delivered beams were calculated for all three cases.
The accuracy of MLC-leaf position determination by VORTE is 0.5 mm (1 standard deviation) by comparison to film measurements. With DRRT, the passing rates using the 2 mm criteria for all acquired frames are 100% for the 2-D displacement, 99% for the 2-D displacement with deformation, and 88% for the 2-D displacement combined with both deformation and rotation. The RMS deviations are 0.6 mm for the 2-D displacement, 1.0 mm for the 2-D displacement with deformation, and 1.1 mm for the 2-D displacement combined with both deformation and rotation.
The VORTE can measure the accuracy of MLC-based tumor tracking without the necessity of employing a moving phantom. Moreover, it can be used for complex target motion (i.e., 2-D displacement combined with deformation and rotation) that is difficult to create with physical moving phantoms. Therefore, the VORTE and the novel QA process illustrated by this study have a great potential for verifying real-time tumor tracking.
作者开发了一种使用电子射野影像装置(EPID)验证剂量率调节跟踪(DRRT)剂量传递的几何精度的新方法。这种名为 EPID 实时跟踪验证(VORTE)的技术,可用于基于多叶准直器的动态肿瘤跟踪的在线和离线质量保证(QA)。
目标的形状和位置随时间变化,假设该信息已知,并将其投影到 EPID 平面上。然后,将随时间变化的目标序列(目标运动)作为参考。通过不使用物理运动体模,就可以评估动态多叶准直器跟踪的准确性,从而评估实际输送光束与所预测目标运动之间的吻合程度。DRRT 控制的射束孔径(孔径运动)随时间由 EPID 检测到。将孔径运动与目标运动进行比较,以评估 DRRT 引入的跟踪误差。通过对十个静态场的胶片测量来测量 VORTE 的准确性。使用 EPID 在连续采集模式下以大约 8 Hz 的速度获取用于动态肿瘤跟踪的受控孔径运动。对于每种目标运动,使用 EPID 在连续采集模式下以大约 8 Hz 的速度获取用于动态肿瘤跟踪的受控孔径运动。从 EPID 测量所有捕获帧中的叶片位置,并将其与预期位置进行比较。对于所有四个肿瘤运动模式,计算了所有帧中所有叶片的 2 毫米标准通过率。此外,还计算了所有三种情况下设计和输送光束之间孔径中心的均方根(RMS)偏差。
与胶片测量相比,VORTE 确定多叶准直器叶片位置的准确性为 0.5 毫米(1 个标准差)。使用 DRRT,对于所有获取的帧,使用 2 毫米标准的通过率为 100%用于二维位移,99%用于二维位移加变形,88%用于二维位移加变形和旋转。RMS 偏差分别为 2 毫米位移的 0.6 毫米、2 毫米位移加变形的 1.0 毫米和 2 毫米位移加变形和旋转的 1.1 毫米。
VORTE 可以在不使用运动体模的情况下测量基于多叶准直器的肿瘤跟踪的准确性。此外,它可以用于复杂的目标运动(即二维位移加变形和旋转),这很难用物理运动体模来实现。因此,VORTE 和本研究所示的新型 QA 流程具有验证实时肿瘤跟踪的巨大潜力。